Ikarian Capital, LLC Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$1.3M
Holdings
126
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (126 positions)
| Stock | Value |
|---|---|
—ACHIEVE LIFE SCIENCE INC | $1.5B |
SPYSPDR S&P 500 ETF TR | $215.9M |
2L9BLUEPRINT MEDICINES CORP | $56.9M |
RETAEURREATA PHARMACEUTICALS INC | $39.1M |
—ZYMEWORKS INC | $32.9M |
NDQINVESCO QQQ TR | $30.9M |
—SUNESIS PHARMACEUTICALS INC | $29.0M |
—ZOGENIX INC | $28.9M |
CCXIEURCHEMOCENTRYX INC | $28.8M |
ARGXARGENX SE | $28.7M |
XBISPDR SER TR | $28.0M |
TCE2CELLDEX THERAPEUTICS INC NEW | $25.0M |
FXIISHARES TR | $23.8M |
BTAIEURBIOXCEL THERAPEUTICS INC | $22.1M |
ASNDASCENDIS PHARMA A S | $21.4M |
MRNAMODERNA INC | $21.2M |
XLRNACCELERON PHARMA INC | $21.2M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $21.0M |
CRBPEURCORBUS PHARMACEUTICALS HLDGS | $19.7M |
VNQVANGUARD INDEX FDS | $19.6M |
ACCUSDAMERICAN CAMPUS CMNTYS INC | $19.2M |
SG7SAGE THERAPEUTICS INC | $17.9M |
—MYOKARDIA INC | $17.4M |
OCULOCULAR THERAPEUTIX INC | $17.1M |
MRTXEURMIRATI THERAPEUTICS INC | $17.1M |
INCYINCYTE CORP | $16.0M |
—HORIZON THERAPEUTICS PUB LTD | $15.8M |
TARAPROTARA THERAPEUTICS INC | $15.5M |
OHIOMEGA HEALTHCARE INVS INC | $14.9M |
MDGLMADRIGAL PHARMACEUTICALS INC | $14.4M |
XLFSELECT SECTOR SPDR TR | $13.9M |
NVAXNOVAVAX INC | $13.7M |
KALVKALVISTA PHARMACEUTICALS INC | $13.5M |
CRSPCRISPR THERAPEUTICS AG | $13.2M |
—STRONGBRIDGE BIOPHARMA PLC | $12.4M |
ITCIEURINTRA CELLULAR THERAPIES INC | $12.0M |
ACADACADIA PHARMACEUTICALS INC | $11.9M |
FGENEURFIBROGEN INC | $11.3M |
MPTMEDICAL PPTYS TRUST INC | $11.3M |
SCPHSCPHARMACEUTICALS INC | $10.8M |
KURAKURA ONCOLOGY INC | $10.0M |
ADVMCHFADVERUM BIOTECHNOLOGIES INC | $9.9M |
ARDXARDELYX INC | $9.6M |
CVM1EURCEL SCI CORP | $9.5M |
—SATSUMA PHARMACEUTICALS INC | $9.5M |
XLESELECT SECTOR SPDR TR | $9.2M |
GOSSGOSSAMER BIO INC | $9.2M |
ICPTUSDINTERCEPT PHARMACEUTICALS IN | $8.9M |
ARVNARVINAS INC | $8.7M |
BLUEBLUEBIRD BIO INC | $8.5M |
—ADURO BIOTECH INC | $7.8M |
—ZYNERBA PHARMACEUTICALS INC | $7.8M |
—CHIASMA INC | $7.7M |
BDTXBLACK DIAMOND THERAPEUTICS I | $7.5M |
IMVTIMMUNOVANT INC | $6.9M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $6.0M |
RAREULTRAGENYX PHARMACEUTICAL IN | $5.9M |
—SOLENO THERAPEUTICS INC | $5.7M |
CBAYUSDCYMABAY THERAPEUTICS INC | $5.3M |
AUPHAURINIA PHARMACEUTICALS INC | $5.3M |
—KADMON HLDGS INC | $5.0M |
CARAEURCARA THERAPEUTICS INC | $5.0M |
OTICEUROTONOMY INC | $5.0M |
1T7TRICIDA INC | $4.9M |
—EIDOS THERAPEUTICS INC | $4.8M |
BMRNBIOMARIN PHARMACEUTICAL INC | $4.7M |
PCVXVAXCYTE INC | $4.4M |
—CHARDAN HEALTHCR ACQSTN 2 CO | $4.2M |
BMY-RBRISTOL-MYERS SQUIBB CO | $3.9M |
AVDLAVADEL PHARMACEUTICALS PLC | $3.9M |
XENEXENON PHARMACEUTICALS INC | $3.7M |
ASMBASSEMBLY BIOSCIENCES INC | $3.7M |
BHVNBIOHAVEN PHARMACTL HLDG CO L | $3.7M |
NERVGBPMINERVA NEUROSCIENCES INC | $3.6M |
NKTREURNEKTAR THERAPEUTICS | $3.5M |
FATEFATE THERAPEUTICS INC | $3.4M |
CLVSEURCLOVIS ONCOLOGY INC | $3.3M |
VSTMVERASTEM INC | $3.3M |
—RESTORBIO INC | $3.1M |
ICADUSDICAD INC | $3.1M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $3.1M |
ALLKGUSDALLAKOS INC | $3.1M |
—APPLIED GENETIC TECHNOLOGIES | $3.0M |
MCRB1EURSERES THERAPEUTICS INC | $2.9M |
BDQMALBIREO PHARMA INC | $2.7M |
—CASI PHARMACEUTICALS INC | $2.6M |
—APTINYX INC | $2.5M |
SLDBSOLID BIOSCIENCES INC | $2.3M |
ALTALTIMMUNE INC | $1.8M |
AXSMAXSOME THERAPEUTICS INC | $1.5M |
CLLSCELLECTIS S A | $1.3M |
MBIOUSDMUSTANG BIO INC | $1.1M |
ADMAADMA BIOLOGICS INC | $1.1M |
—CERECOR INC | $1.0M |
BBIOBRIDGEBIO PHARMA INC | $1.0M |
DCTHDELCATH SYS INC | $964K |
—DICERNA PHARMACEUTICALS INC | $902K |
—DBV TECHNOLOGIES S A | $723K |
KNSAKINIKSA PHARMACEUTICALS LTD | $720K |
IFRXINFLARX NV | $700K |
Page 1 of 2Next